Discover 2,413 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,413
Post-Concussion Musculoskeletal Injury Risks
for
Musculoskeletal Injury
Location: Bethesda MD, Athens GA
Sponsor: Walter Reed National Military Medical Center
Sex: All
Age: 18 - 40
Code: NCT05122728
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Bethesda MD, Washington D.C. DC, Olney MD, Clinton MD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
for
Rotator Cuff Tears, Rotator Cuff Injuries, Surgery
Location: Bethesda MD, Durham NC, Chapel Hill NC, San Antonio TX,
Sponsor: Walter Reed National Military Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06034509
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
for
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma,
Location: Bethesda MD, Fairfax VA, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 45 - 70+
Code: NCT06995898
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
for
Hypogonadism, Gender Identity Dysphoria
Location: Bethesda MD
Sponsor: Walter Reed National Military Medical Center
Sex: All
Age: 18 - 65
Code: NCT06247267
Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Bethesda MD, Charlottesville VA, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Bethesda MD, Washington D.C. DC, Falls Church VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Bethesda MD, Washington D.C. DC, Baltimore MD,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase2, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Bethesda MD, Fairfax VA, Falls Church VA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT00977977
Phase2, Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Bethesda MD, Fairfax VA, Falls Church VA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase2, Recruiting
Pilonidal Disease Wound Healing Study
for
Pilonidal Disease
Location: Bethesda MD
Sponsor: Walter Reed National Military Medical Center
Sex: All
Age: 18 - 60
Code: NCT01857128
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Bethesda MD, Fairfax VA, Falls Church VA, Hershey PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
for
Post Operative Surgical Site Infection
Location: Bethesda MD, Falls Church VA, Baltimore MD,
Sponsor: Major Extremity Trauma Research Consortium
Sex: All
Age: 18 - 64
Code: NCT04678154
Phase3, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Bethesda MD, Washington D.C. DC, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Bethesda MD, Washington D.C. DC, Falls Church VA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Bethesda MD, Fairfax VA, Falls Church VA,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Bethesda MD, Hershey PA, Charlottesville VA,